USPTO serial 98495156
VYTRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURKE, JUSTINE N
- Law office
- TMO LAW OFFICE 121
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with VYTRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Austin, TX, US
Austin, TX, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amit Kulkarni
5911 Leisure Run RoadAustin, TX 78745United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Pressure measuring apparatus; Recorded Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Recorded Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the heart; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; Software as a Medical Device (SaMD), recorded, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), recorded, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), recorded, for use as a medical instrument for vital sign monitoring | ACTIVE | May 25, 2023 |
| 010 | Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing suspected heart attacks; Medical apparatus for monitoring blood glucose levels; Medical apparatus for monitoring vital signs of patients; Medical apparatus for preventing or reversing heart failure; Medical apparatus for the treatment of respiratory conditions; Medical apparatus for use in treating abnormal vital signs; Medical apparatus, namely, fetal and maternal vital sign and physical distress monitors; Medical apparatus, namely, respiratory equipment and monitors therefor; Medical device used for the acquisition of physiological data for polysomnography; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of recorded software for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for treating congestive heart failure; Medical devices for use in diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs with integrated recorded operating system software, sold as a unit; Medical devices for use in treating abnormal vital signs; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse generators for vital sign monitoring; Medical and surgical apparatus and instruments for use in vital sign monitoring procedures; Medical diagnostic apparatus for testing vital signs; Medical diagnostic apparatus for testing vital signs incorporating recorded software for vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring; Medical imaging apparatus for vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring incorporating recorded software for vital sign monitoring; Medical imaging apparatus with embedded operating system software; Medical imaging devices for vital sign monitoring; Blood pressure and diabetic diagnostic medical devices; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Diagnostic apparatus for medical purposes used in medical laboratories for testing vital signs; Manometers for medical purposes being arterial blood pressure measuring apparatus; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Surgical and medical apparatus and instruments for use in general surgery; Surgical and medical apparatus and instruments for use in vital sign monitoring during surgery; Ultrasound apparatus for medical purposes; Ultrasound apparatus for medical use | ACTIVE | May 25, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 16, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 26, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 25, 2025 | IUAF | USE AMENDMENT FILED | — |
| Sep 25, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 25, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 28, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 28, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 26, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2024 | NWAP | NEW APPLICATION ENTERED | — |